Semaglutide is a long?acting GLP?1 receptor analogue synthetic peptide. It is modified based on native GLP?1 sequence with fatty?acid side?chain modification, which greatly improves plasma half?life. It acts by activating GLP?1 receptor and participates in glucose metabolism, insulin secretion and appetite?related pre?clinical mechanism research.

In scientific research, Semaglutide is widely applied in pre?clinical projects covering glucose homeostasis, insulin sensitivity, energy metabolism, obesity?related mechanism and metabolic disease model study. It can be used for cell?level experiments and animal model research.

Our Semaglutide peptide is synthesized by mature solid?phase peptide synthesis technology. Each batch is strictly tested by HPLC and mass spectrometry to verify purity and molecular structure. COA document is available upon customer request. Lyophilized powder guarantees stability during transportation and long?term storage. Multiple packing specifications are supported, including lab?scale sample vials and bulk large?quantity orders.

Warning: This product is exclusively for scientific laboratory research. It shall not be used for human consumption, injection, clinical diagnosis or therapy.

Ready for Gedai chemical website upload. Tell me next peptide name.